✦ LIBER ✦

Pharmacodynamics of different isosorbide-5-mononitrate formulations in patients with stable angina pectoris

✍ Scribed by V.I. Metelitsa; S.Yu. Martsevich; I.D. Slastnikova; L.S. Simkhaev; S.V. Blagodatskikh

Book ID: 115885249
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 213 KB
Volume: 183
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(90)93421-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute and sustained effects of isosorbid

Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris

✍ Ravinder S. Kohli; Erwin A. Rodrigues; Mohammed M. Kardash; John R. Whittington; 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 577 KB

Effects of diltiazem and isosorbide-5-mo

Effects of diltiazem and isosorbide-5-mononitrate, alone and in combination, on patients with stable angina pectoris

✍ H. Emanuelsson; H. Åke; M. Kristi; R. Arina 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 643 KB

Effect of Extended-Release Isosorbide Mo

Effect of Extended-Release Isosorbide Mononitrate One Hour After Dosing in Patients With Stable Angina Pectoris

✍ Stephen P. Glasser MD 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Effects of isosorbide-5-mononitrate on e

Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris

✍ Mitsuhiro Yokota; Atsushi Tsunekawa; Takashi Miyahara; Susumu Kamihara; Jiro Kit 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 606 KB

Usefulness of twice-daily isosorbide-5-m

Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris

✍ Udho Thadani; Rajesh Prasad; Stephen F. Hamilton; Wyatt Voyles; Ralph Doyle; Ser 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 769 KB

A new isosorbide dinitrate extended-rele

A new isosorbide dinitrate extended-release formulation: pharmacokinetic and clinical parameters in patients with stable angina pectoris

✍ T. O. Klemsdal; H. H. Mundal; K. Gjesdal; N. Rudberg 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 399 KB

In a double-blind, cross-over study the acute clinical efficacy and pharmacokinetic profile of a newly developed isosorbide dinitrate extended-release (ISDN-ER) formulation (10 mg immediate release and 60 mg slow release) were examined in eight angina patients. Exercise tests were done 1 h before an